Artixio

Product Registration in South Korea | Compliance Support

Life Sciences Product Registration in South Korea

Comprehensive support for securing product approvals and regulatory compliance across all life sciences sectors in South Korea.

Product Registration Consulting Services in South Korea

In South Korea, the regulatory environment for life sciences products requires a thorough understanding of local laws and standards. Artixio offers expert support in securing product approvals, handling complex documentation, and ensuring compliance across all industries, from pharmaceuticals to medical devices.

We handle all aspects of product registration, from initial classification and documentation to submission and post-market compliance. Our local knowledge and international experience help reduce delays and improve approval chances, making us a trusted partner in South Korea’s regulatory space.

Regulatory Authorities in South Korea

Regulatory Body Industry
Ministry of Food and Drug Safety (MFDS) Pharmaceuticals, Medical Devices, Biologics, Cosmetics
Korea Food and Drug Administration (KFDA) Pharmaceuticals, Biologics
Korea Institute of Industrial Technology (KIIT) MedTech, Medical Devices
Korea Health Industry Development Institute (KHIDI) Pharmaceuticals, MedTech, Biologics
Animal and Plant Quarantine Agency (APQA) Veterinary Products, Animal Health

Product Registration Lifecycle in South Korea

We manage the entire lifecycle of product registration in South Korea:
Initial Product Assessment
Documentation & Dossier Preparation
Submission to Regulatory Authorities
Approval & Licensing
Post-Market Compliance

Why Choose Artixio for Product Registration in South Korea

FAQs

Do I need local clinical data for product approval in South Korea?
Yes, local clinical data may be required, especially for pharmaceuticals and medical devices, depending on the product’s classification.
Required documents include product classification, technical dossiers, clinical trial data (if applicable), labeling, and manufacturing certificates.
Our team will assess your product based on its category (pharmaceuticals, medical devices, cosmetics, etc.) and determine if MFDS approval is required.
We provide regular updates throughout the process and ensure you are informed at every stage, from submission to approval.

Still Have Questions ?

Get expert answers tailored to your needs.

Specialized Registration Services Across Multiple Industries

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

Expert Regulatory Services To Streamline Compliance

Regulatory Intelligence & Strategy
Medical & Technical Writing
Publishing & Submission
Product Registration
Investigation New Drug Application (IND)
New Drug Application (NDA)
Post Approval Lifecycle Maintenance
Artwork and Label Review
Ad Promo Review

Regulatory Affairs Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Orphan Drug Designation in South Korea (MFDS)

Orphan Drug Designation in

Orphan Drug Designation (ODD) is regulated by Ministry of Food and Drug Safety (MFDS)...

November 4, 2025
Prioritizing Genes from Publicly Available GWAS Summary Stats Using AI

Prioritizing Genes from Publicly

Artixio has developed an artificial intelligence based solution generating a list of prioritized genes...

October 13, 2025
CDSCO Simplifies Subsequent Importer Process for Medical Devices & IVDs

CDSCO Simplifies Subsequent Importer

India’s regulatory authority, the Central Drugs Standard Control Organization (CDSCO), has published an important...

October 3, 2025